Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
0.1925
Nov 18 • 3:23 PM ET Dollar change-0.0175 Percentage change(-8.33%)
Index
-
Market Cap
0.87M
Enterprise Value
-0.96M
Income
-9.62M
Sales
0.00M
Book/sh
0.24
Cash/sh
0.49
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
3
IPO
Oct 21, 2003
P/E
-
Forward P/E
-
PEG
-
P/S
-
P/B
0.80
P/C
0.39
P/FCF
-
EV/EBITDA
-
EV/Sales
-
Quick Ratio
1.50
Current Ratio
1.50
Debt/Eq
0.37
LT Debt/Eq
0.00
Option/Short
No / Yes
EPS (ttm)
-2.20
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
72.24% 64.78%
Sales past 3/5Y
- -
EPS Y/Y TTM
86.87%
Sales Y/Y TTM
-
EPS Q/Q
70.63%
Sales Q/Q
-
Earnings
-
EPS/Sales Surpr.
- -
Insider Own
0.17%
Insider Trans
0.00%
Inst Own
2.42%
Inst Trans
-1.37%
ROA
-120.35%
ROE
-176.13%
ROIC
-880.59%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
SMA20
-42.68%
SMA50
-54.10%
SMA200
-66.23%
Trades
Shs Outstand
4.51M
Shs Float
4.50M
52W High
1.11 -82.66%
52W Low
0.17 15.48%
Volatility
15.62% 8.90%
ATR (14)
0.03
RSI (14)
17.00
Beta
1.38
Rel Volume
0.31
Avg Volume
822.73K
Volume
238,240
Perf Week
-43.56%
Perf Month
-55.65%
Perf Quarter
-64.35%
Perf Half Y
-67.07%
Perf YTD
-75.42%
Perf Year
-82.22%
Perf 3Y
-99.82%
Perf 5Y
-99.98%
Perf 10Y
-100.00%
Prev Close
0.21
Price
0.19
Change %
-8.33%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Telling FredDirectorDec 12 '25Sale0.9421019834,538Dec 15 04:38 PM
Frederick W. TellingDirectorDec 12 '25Proposed Sale0.91210192Dec 12 06:28 PM
Oragenics, Inc. operates as a development-stage company, which engages in research and development of potential therapies to fight infectious diseases including coronaviruses and multidrug-resistant organisms. Its technology and pipeline consist of antibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Lakewood Ranch, FL.
CEOMs. Janet Huffman
Chief Financial OfficerMr. John Spencer
M.D.Dr. James P. Kelly M.A.
F.A.C.E.P.Dr. William Franklin Peacock IV